Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs AT&T Inc. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while AT&T Inc. trades at $23.31 (market cap $157.95B). The key difference: AT&T Inc. is far larger — about 5.1× GE HealthCare Technologies Inc. Common Stock's market cap, and AT&T Inc. pays the higher dividend (4.82%). Which is the better fit depends on your goals.
| GEHC | T | |
|---|---|---|
Market Cap | $30.93B | $157.95B |
Volume | 5,033,451 | 40,269,473 |
Sector | Health | Media |
52-Week High | $88.16 | $29.10 |
52-Week Low | $59.48 | $20.49 |
Enterprise Value | $39.39B | $303.27B |
Dividend Yield | 0.23% | 4.82% |
Typical Hold Time | — | 118 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
AT&T (T) trades at $22.86, up 1.65% today, showing strong fundamental performance with a low P/E of 7.54 and robust profitability metrics including 16.94% net margin. The company has beaten earnings estimates for three consecutive quarters and maintains solid cash flow generation of $15.12B in 2025. Technical indicators show mixed signals with bearish moving averages but bullish oscillators, while analyst consensus remains divided with a $27.39 price target.
The stock presents value investment characteristics with attractive valuation multiples and consistent dividend payments. Key opportunities include fiber expansion initiatives and wireless growth, while risks center on heavy debt load and competitive pressures. The current price near support levels offers potential upside to analyst targets, though technical weakness requires monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
